Stomach Ulcer Clinical Trial
Official title:
A Post-marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy
To examine the efficacy of continued administration of rebamipide following bacteria eradication therapy in patients with H. pylori-positive active gastric ulcer in a placebo-controlled, double-blind study
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02299687 -
Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole
|
Phase 1 | |
Completed |
NCT00284908 -
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00239551 -
Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
|
Phase 4 | |
Completed |
NCT02710994 -
Pharmacodynamics and Safety of CDFR0209
|
Phase 1 | |
Completed |
NCT01167101 -
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?
|
N/A | |
Terminated |
NCT00762359 -
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
|
Phase 3 | |
Completed |
NCT01376414 -
H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department
|
N/A | |
Completed |
NCT00543868 -
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
|
Phase 2 | |
Completed |
NCT05208268 -
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
|
||
Completed |
NCT02032030 -
Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
|
||
Completed |
NCT00272467 -
Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy
|
Phase 4 | |
Completed |
NCT03060746 -
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
|
||
Completed |
NCT03060733 -
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
|
||
Completed |
NCT00125736 -
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
|
Phase 4 | |
Terminated |
NCT00839488 -
Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis
|
Phase 4 | |
Completed |
NCT00787254 -
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
|
Phase 3 | |
Completed |
NCT00190255 -
Pharmacogenetics of Gastrointestinal Bleeding
|
Phase 4 |